Hemostemix Inc V.HEM

Alternate Symbol(s): HMTXF

Healthcare Biotechnology

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01 is a lead clinical-stage candidate, like NCP-01 and CCP-01, is generated from the patient’s blood. The Company is engaged in providing treatment for ischemia, such as ischemic cardiomyopathy, angina, peripheral arterial disease including critical limb ischemia. The Company’s proprietary technology is a personalized regenerative therapy that is administered to a patient within seven days of the initial blood draw. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd., and PreCerv Inc.

TSXV:HEM - Post by User

Hemostemix Inc

Bullboard Posts

Post by barmac6on Dec 21, 2010 3:24pm

296 Views

Post# 17878102

Wellington putting their money where their mouth i

House Positions for HEM from 20101221 to 20101221

House	Bought	$Value	Ave	Sold	$Value	Ave	Net	$Net
12 Wellington	144,500	148,920	1.03	0			144,500	-148,920
73 Cormark	24,500	24,255	0.99	0			24,500	-24,255
1 Anonymous	1,000	1,000	1.00	1,000	1,040	1.04	0	40
33 Canaccord	0			400	420	1.05	-400	420
80 National Bank	0			10,000	9,920	0.99	-10,000	9,920
124 Questrade	0			12,200	12,720	1.04	-12,200	12,720
79 CIBC	1,500	1,525	1.02	14,900	15,293	1.03	-13,400	13,768
85 Scotia	0			14,000	14,500	1.04	-14,000	14,500
89 Raymond James	2,015	2,068	1.03	21,200	22,080	1.04	-19,185	20,012
7 TD Sec	5,700	5,665	0.99	27,010	27,414	1.01	-21,310	21,749
9 BMO Nesbitt	0			28,070	29,260	1.04	-28,070	29,260
2 RBC	6,500	6,510	1.00	56,935	57,296	1.01	-50,435	50,786
Total	185,715	189,943	1.02	185,715	189,943	1.02	0	0